Company: BGLC
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001477932-25-002725
Chunk: 935

Company: BioNexus Gene Lab Corp
Filing Date: 2025-04-15
Form: 10-K
Item: Item 5
Chunk 935
---
1,376,571   799,674 Other receivables, deposits and prepayments      203,660   122,432 Tax recoverable  4   84,167   57,588 Inventories (including goods in transit of $188,797 and $Nil as of December 31, 2024 and 2023 respectively)      1,388,624   1,137,770 Total current assets      7,430,449   8,046,800              NON-CURRENT ASSETS            Operating lease right-of-use assets  5   215,243   141,544 Property, plant and equipment, net  6   1,522,990   1,511,618 Investments in equity securities  7   1,265,166   1,699,831 Total non-current assets      3,003,399   3,352,993 TOTAL ASSETS     $10,433,848  $11,399,793              LIABILITIES AND STOCKHOLDERS’ EQUITY            CURRENT LIABILITIES            Trade payables (including $Nil and $21,953 of trade payables from related parties for December 31, 2024 and 2023 respectively)  8   1,503,326   1,402,180 Other payables and accrued liabilities      284,108   180,912 Current portion of operating lease liabilities  5   50,816   34,632 Advance payment from customer      95,879   - Amount owing to directors      17,174   13,199 Total current liabilities      1,951,303   1,630,923              NON-CURRENT LIABILITIES            Non-current portion of operating lease liabilities  5   159,741   98,763 Deferred tax liabilities  4   -   12,255 Total non-current liabilities      159,741   111,018 TOTAL LIABILITIES     $2,111,044  $1,741,941 

See accompanying notes to the consolidated financial statements.

 F-4Table of Contents

PART I — FINANCIAL INFORMATION

ITEM 1.